ANAPTYSBIO, INC Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANAPTYSBIO, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANAPTYSBIO, INC for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Schoeneck James A | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Schmid John P. | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | RENTON HOLLINGS | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Gallagher Carol Giltner | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | A | 24.60 | 75,000 | 1,845,000 | 75,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | MOYLE MATTHEW | Chief Scientific Of ... | Option Exercise | A | 24.60 | 75,000 | 1,845,000 | 75,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | A | 24.60 | 110,000 | 2,706,000 | 110,000 | |
| Feb 28 2017 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | A | 24.60 | 225,000 | 5,535,000 | 225,000 | |
| Feb 06 2017 | ANAB | ANAPTYSBIO INC | Frazier Healthcare VII, L.P. | 10% Owner | Option Exercise | X | 4.55 | 117,235 | 533,419 | 0 | |
| Feb 06 2017 | ANAB | ANAPTYSBIO INC | Frazier Healthcare VII, L.P. | 10% Owner | Buy | X | 4.55 | 117,235 | 533,419 | 2,345,612 | 2.2 M to 2.3 M (+5.26 %) |
| Feb 06 2017 | ANAB | ANAPTYSBIO INC | Frazier Healthcare V, LP | 10% Owner | Option Exercise | X | 4.55 | 117,235 | 533,419 | 0 | |
| Feb 06 2017 | ANAB | ANAPTYSBIO INC | Frazier Healthcare V, LP | 10% Owner | Buy | X | 4.55 | 117,235 | 533,419 | 2,345,612 | 2.2 M to 2.3 M (+5.26 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | X | 4.55 | 117,235 | 533,419 | 0 | |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 673,454 | 0 | 0 | |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 312,986 | 0 | 0 | |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 486,820 | 0 | 0 | |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,428,571 | 0 | 0 | |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | P | 15.00 | 50,000 | 750,000 | 3,033,504 | 3 M to 3 M (+1.68 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | X | 0.00 | 81,673 | 0 | 2,983,504 | 2.9 M to 3 M (+2.81 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 673,454 | 0 | 2,901,831 | 2.2 M to 2.9 M (+30.22 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 312,986 | 0 | 2,228,377 | 1.9 M to 2.2 M (+16.34 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 486,820 | 0 | 1,915,391 | 1.4 M to 1.9 M (+34.08 %) |
| Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,428,571 | 0 | 1,428,571 | 0 to 1.4 M |